To investigate whether PUS10 could act as a tumor suppressor in RCC, we silenced PUS10 in 786-O and Caki-1 cells using two siRNAs, and the knockdown efficiency was examined at the mRNA and protein levels (Fig. 2A and B, Additional file 4: Figure S2A). Here, PUS10 is linked to renal cell carcinoma.